Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia

Clinica Chimica Acta

Volumn 404, Issue 2, 2009, Pages 149-153

  Li, Hung Yuan ^a,b   Wei, Jung Nan ^c   Lin, Mao Shin ^a,b   Smith, David J ^d   Vainio, Jani ^d   Lin, Cheng Hsin ^e   Chiang, Fu Tien ^a   Shih, Shyang Rong ^a   Huang, Ching Huei ^a   Wu, Mei Yu ^a   Hsein, Yenh Chen ^a   Chuang, Lee Ming ^a,b,f  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^d Biotie Therapies Corp   (Finland)

^e CHI MEI MEDICAL CENTER   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Amine oxidase; Copper containing 3 (AOC3); Diabetes mellitus; Diabetic complications; Semicarbazide sensitive amine oxidase; Vascular adhesion protein 1

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; VASCULAR ADHESION PROTEIN 1;

ADULT; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

ACUTE DISEASE; AGED; AMINE OXIDASE (COPPER-CONTAINING); BIOLOGICAL MARKERS; BLOOD GLUCOSE; CELL ADHESION MOLECULES; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED;

EID: 67349219121     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.03.041     Document Type: Article

References (38)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care 27 (2004) 1047-1053
2. LeRoith D., Taylor S.I., and Olefsky J.M. Diabetes mellitus: a fundamental and clinical text. 3rd ed. (2003), Lippincott Williams & Wilkins, Philadelphia
3. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54 (2005) 1615-1625
4. Garpenstrand H., Ekblom J., Backlund L.B., Oreland L., and Rosenqvist U. Increased plasma semicarbazide-sensitive amine oxidase (SSAO) activity in type 2 diabetes mellitus complicated by retinopathy. Diabet Med 16 (1999) 514-521
5. Boomsma F., van den Meiracker A.H., Winkle S., et al. Circulating semicarbazide-sensitive amine oxidase is raised both in Type I (insulin-dependent), in Type II (non-insulin-dependent) diabetes mellitus and even in childhood Type I diabetes at first clinical diagnosis. Diabetologia 42 (1999) 233-237
6. Meszaros Z., Szombathy T., Raimondi L., Karadi I., Romics L., and Magyar K. Increased serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism 48 (1999) 113-117
7. Jalkanen S., and Salmi M. Cell surface monoamine oxidases: enzymes in search of a function. EMBO J 20 (2001) 3893-3901
8. Yu P.H., Wright S., Fan E.H., Lun Z.R., and Gubisne-Harberle D. Physiological and pathological implications of semicarbazide-sensitive amine oxidase. Biochim Biophys Acta 1647 (2003) 193-199
9. Ishizaki F. Plasma benzylamine oxidase activity in cerebrovascular disease. Eur Neurol 30 (1990) 104-107
10. Garpenstrand H., Ekblom J., Backlund L.B., Oreland L., and Rosenqvist U. Increased plasma semicarbazide-sensitive amine oxidase (SSAO) activity in Type 2 diabetes mellitus complicated by retinopathy. Diabet Med 16 (1999) 514-521
11. Gronvall-Nordquist J.L., Backlund L.B., Garpenstrand H., et al. Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in Type 2 diabetes mellitus. J Diabetes Complications 15 (2001) 250-256
12. Dura E., Meszaros Z., Salacz G., Magyar K., Romics L., and Karadi I. [Determination of serum semicarbazide-sensitive amine oxidase activity in diabetic retinopathy in type-2 diabetes]. Orv Hetil 143 (2002) 2637-2644
13. Boomsma F., Derkx F.H., van den Meiracker A.H., Man in 't Veld A.J., and Schalekamp M.A. Plasma semicarbazide-sensitive amine oxidase activity is increased in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci (Lond) 88 (1995) 675-679
14. Salmi M., Stolen C., Jousilahti P., et al. Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes. Am J Pathol 161 (2002) 2255-2262
15. Merinen M., Irjala H., Salmi M., Jaakkola I., Hanninen A., and Jalkanen S. Vascular adhesion protein-1 is involved in both acute and chronic inflammation in the mouse. Am J Pathol 166 (2005) 793-800
16. Mazzone T., Chait A., and Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 371 (2008) 1800-1809
17. Monnier L., Mas E., Ginet C., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
18. Lin M.S., Li H.Y., Wei J.N., et al. Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease. Clin Biochem 41 (2008) 1362-1367
19. Boomsma F., Bhaggoe U.M., van der Houwen A.M., and van den Meiracker A.H. Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology. Biochim Biophys Acta 1647 (2003) 48-54
20. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
21. Levy J.C., Matthews D.R., and Hermans M.P. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes care 21 (1998) 2191-2192
22. Li H.Y., Lee W.J., Chen M.J., and Chuang L.M. Change in vascular adhesion protein-1 and metabolic phenotypes after vertical banded gastroplasty for morbid obesity. Obes Res 13 (2005) 855-861
23. Diagnosis and classification of diabetes mellitus. Diabetes Care 27 Suppl 1 (2004) S5-S10
24. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 18 (1995) 258-268
25. Stratton I.M., Adler A.I., Neil H.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
26. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44 (1995) 968-983
27. Bonora E., and Muggeo M. Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence. Diabetologia 44 (2001) 2107-2114
28. Ceriello A., Hanefeld M., Leiter L., et al. Postprandial glucose regulation and diabetic complications. Arch Intern Med 164 (2004) 2090-2095
29. Monnier L., Mas E., Ginet C., et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
30. Nouri-Aria K.T., Koskinas J., Tibbs C.J., Portmann B.C., and Williams R. Serum intercellular adhesion molecule-1 levels in chronic hepatitis C: association with disease activity and response to interferon alpha. Gut 36 (1995) 599-603
31. Adams D.H., Mainolfi E., Burra P., et al. Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology 16 (1992) 810-814
32. Gubisne-Haberle D., Hill W., Kazachkov M., Richardson J.S., and Yu P.H. Protein cross-linkage induced by formaldehyde derived from semicarbazide-sensitive amine oxidase-mediated deamination of methylamine. J Pharmacol Exp Ther 310 (2004) 1125-1132
33. Jalkanen S., Karikoski M., Mercier N., et al. The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood 110 (2007) 1864-1870
34. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 Suppl 1 (2003) S5-20
35. McCance D.R., Hanson R.L., Charles M.A., et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308 (1994) 1323-1328
36. Engelgau M.M., Thompson T.J., Herman W.H., et al. Comparison of fasting and 2-h glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 20 (1997) 785-791
37. Stolen C.M., Yegutkin G.G., Kurkijarvi R., Bono P., Alitalo K., and Jalkanen S. Origins of serum semicarbazide-sensitive amine oxidase. Circ Res 95 (2004) 50-57
38. Abella A., Garcia-Vicente S., Viguerie N., et al. Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 47 (2004) 429-438